Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2013
12/19/2013US20130337545 Minicell based delivery of biologically active compounds
12/19/2013US20130337544 Methods and composition for the identification of antibiotics that are not susceptible to antibiotic resistance
12/19/2013US20130337543 Aav4 vector and uses thereof
12/19/2013US20130337540 Novel Class of Therapeutic Protein Based Molecules
12/19/2013US20130337514 PRODUCTION OF POLYUNSATURATED FATTY ACIDS BY COEXPRESSION OF ACYL-CoA:LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASES AND PHOSPHOLIPID:DIACYLGLYCEROL ACYLTRANSFERASES
12/19/2013US20130337507 Xylanases, Nucleic Acids Encoding Them and Methods for Making and Using Them
12/19/2013US20130337459 A method of enhancing mir-185 expression to reduce low density lipoprotein/cholesterol accumulation in a cell
12/19/2013US20130337454 Method for increasing the efficiency of double-strand break-induced mutagenesis
12/19/2013US20130337446 Method of preparing a standard diagnostic gene transcript pattern
12/19/2013US20130337443 Methods for detecting dna prioginating from different individuals
12/19/2013US20130337049 Novel Use of Spiegelmers
12/19/2013US20130337039 Internalizing ErBB2 Antibodies
12/19/2013US20130337011 Recombinant mycobcterium as a vaccine
12/19/2013US20130337010 Reassortant btv and ahsv vaccines
12/19/2013US20130337009 Chimeric dna vaccine compositions and methods of use
12/19/2013US20130336991 Sp35 Antibodies and Uses Thereof
12/19/2013US20130336990 Enhancement of the action of anti-infective agents and of central and peripheral nervous system agents and transportation of nucleic acid substances
12/19/2013US20130336987 Identification of Therapeutic Targets in Cutaneous SCC
12/19/2013US20130336983 Prognosis and treatment of breast cancer
12/19/2013US20130336979 Diagnostic and treatment of chronic heart failure
12/19/2013US20130336956 Recombinant elastase proteins and methods of manufacturing and use thereof
12/19/2013US20130336954 Staphylococcal Phage2638A Endolysin Amidase Domain Is Lytic for Staphylococcus aureus
12/19/2013DE112012001020T5 Pflanzen mit gesteigerten Ertragsmerkmalen und Verfahren zu deren Herstellung Plants having enhanced yield-related traits and processes for their preparation
12/19/2013DE112012001017T5 Pflanzen mit gesteigerten Ertragsmerkmalen und Verfahren zu deren Herstellung Plants having enhanced yield-related traits and processes for their preparation
12/19/2013DE102012210155A1 Extracting specific blood components from liquid whole blood, comprises e.g. mixing whole blood sample with buffer, lysis enzyme and nucleic acid-binding magnetic bead dispersion, releasing nucleic acids by lysis and isolating and purifying
12/19/2013CA2877669A1 Dual receptor antagonistic antigen-binding proteins and uses thereof
12/19/2013CA2876868A1 Methods of preparing pluripotent stem cells
12/19/2013CA2876824A1 Nucleic acids for treatment of allergies
12/19/2013CA2876796A1 Humanized antibodies to ca215
12/19/2013CA2876558A1 Biological method for producing cis-5-hydroxy-l-pipecolic acid
12/19/2013CA2876550A1 Cho expression system
12/19/2013CA2876519A1 Production of long chain polyunsaturated fatty acids in plant cells
12/19/2013CA2876469A1 Transgenic mouse models for mc4r
12/19/2013CA2876426A1 Methods and compositions involving als variants with native substrate preference
12/19/2013CA2876076A1 Methods and compositions for generating conditional knock-out alleles
12/19/2013CA2875689A1 Method for producing high-quality recombinant allergens in a plant
12/19/2013CA2875666A1 Compositions and methods for sensitive mutation detection in nucleic acid molecules
12/19/2013CA2875453A1 Biotechnological 2-hydroxyisobutyric acid production
12/18/2013EP2674502A1 Biological specimen collection/transport compositions and methods
12/18/2013EP2674499A1 Method for producing target substance by fermentation process
12/18/2013EP2674497A1 A light regulated transgene expression system
12/18/2013EP2674496A2 Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress
12/18/2013EP2674495A1 CHO expression system
12/18/2013EP2674494A1 Single-stranded RNA molecule having nitrogen-containing alicyclic skeleton
12/18/2013EP2674493A1 RNAi-mediated inhibition of histamine receptor H1-related conditions
12/18/2013EP2674492A1 Method for detecting nucleic acid
12/18/2013EP2674491A1 Method for producing virus vector for gene transfer
12/18/2013EP2674490A1 Phenylpyruvate reductase and method for manufacturing optically-active phenyllactic acid and 4-hydroxyl-phenyllactic acid using same enzyme
12/18/2013EP2674489A1 Biotechnological 2-hydroxyisobutyric acid production
12/18/2013EP2674488A1 Variants of a family 44 xyloglucanase
12/18/2013EP2674483A1 Engineered dendritic cells and uses for the treatment of cancer
12/18/2013EP2674438A2 System Overexpressing baculovirus transactivators for the production of Recombinant Proteins
12/18/2013EP2673365A1 Modified plant defensins useful as anti-pathogenic agents
12/18/2013EP2673364A1 Aptamers to tissue factor pathway inhibitor and their use as bleeding disorder therapeutics
12/18/2013EP2673363A2 Treatment of angiogenesis disorders
12/18/2013EP2673362A1 B-type plexin antagonists and uses thereof
12/18/2013EP2673361A1 Oligomeric compounds comprising bicyclic nucleotides and uses thereof
12/18/2013EP2673359A2 Reverse transcriptase having improved thermostability
12/18/2013EP2673358A2 Hematopoietic precursor cell production by programming
12/18/2013EP2673353A1 Cellulase enzyme mixtures for depilling and uses thereof
12/18/2013EP2673294A1 Mutant interleukin-2 polypeptides
12/18/2013EP2673290A1 Filamentous fungi having an altered viscosity phenotype
12/18/2013EP2673289A1 Viral vectors with modified transduction profiles and methods of making and using the same
12/18/2013EP2673286A1 Therapeutic compounds
12/18/2013EP2672989A1 Immunogenic composition comprising alpha-hemolysin oligopeptides
12/18/2013EP2672977A1 Antisense oligonucleotides
12/18/2013EP2451474B1 Codon-optimized factor viii variants and synthetic liver-specific promoter
12/18/2013EP2401366B1 Transaminase biocatalysts
12/18/2013EP2344528B1 Pharmaceutical being used for treating cancer and fibrosis disease and the composition and uses thereof
12/18/2013EP2333118B1 Method for rapid detection and identification of bioagents
12/18/2013EP2331557B1 Alphavirus packaging cell lines
12/18/2013EP2322649B1 Method for rapid detection and identification of bioagents
12/18/2013EP2284263B1 Primer and probe for use in detection of mycobacterium kansasii and method for detection of mycobacterium kansasii using the same
12/18/2013EP2246362B1 Polymer conjugates of mutated neublastin
12/18/2013EP2177626B1 Screening methods for cognitive enhancers
12/18/2013EP2158314B1 A method for identifying a pork content in a food
12/18/2013EP2126096B1 Methods for plant transformation using spectinomycin selection
12/18/2013EP2092069B2 Modified soluble fgf receptor fc fusions with improved biological activity
12/18/2013EP2019136B1 Method for detecting or quantifying wheat endogenous dna and method for determining contamination rate of genetically modified wheat in test sample
12/18/2013EP1929010B1 Uses of polymer particles
12/18/2013EP1782800B1 Methods for detecting JAK3 inhibitors
12/18/2013EP1663110B1 Uses of interferons with altered spatial structure
12/18/2013EP1606407B1 Modulation of exon recognition in pre-mrna by interfering with the secondary rna structure
12/18/2013EP1507791B1 Antisense antiviral agent and method for treating ssrna viral infection
12/18/2013EP0647275B2 Cloning and expression of gonadotropin-releasing hormone receptor
12/18/2013CN103459608A Recombinant polypeptide production method
12/18/2013CN103459601A Synthetic insecticidal proteins with active against corn rootworm
12/18/2013CN103459600A A method for the production of a compound of interest
12/18/2013CN103459599A Treatment of NANOG related diseases by inhibition of natural antisense transcript to NANOG
12/18/2013CN103459598A Synthetic mimics of mir-124
12/18/2013CN103459597A Marker for predicting stomach cancer prognosis and method for predicting stomach cancer prognosis
12/18/2013CN103459596A Targeted alteration of DNA
12/18/2013CN103459595A Antibody against human prostaglandin E2 receptor EP4
12/18/2013CN103459588A Kluyveromyces yeast mutant and method for producing ethanol using same
12/18/2013CN103459587A In situ expression of lipase for enzymatic production of alcohol esters during fermentation
12/18/2013CN103459586A Cellulase enzyme mixtures for depilling and uses thereof
12/18/2013CN103459426A Novel anti-human IL-23 receptor antibody
12/18/2013CN103459414A Protein having antigen activity against liver flukes
12/18/2013CN103459413A Powdery mildew resistance providing genes in cucumis melo
12/18/2013CN103459411A Antimicrobial peptide multiblock copolymer to be expressed on surface of cells